About Cipla Limited (CIPLA)
Cipla Limited is a Drug Manufacturers - Specialty & Generic company operating in the Healthcare sector. The company is headquartered in Mumbai, India. CIPLA has been publicly traded since 1996, giving it 30+ years of trading history.
Cipla Limited (CIPLA) has been publicly traded since 1996, making it a 30-year-old public company. It operates in the Drug Manufacturers - Specialty & Generic industry within the Healthcare sector. The company is headquartered in Mumbai, India and employs approximately 30,313 people. With a market capitalization of $1.1 trillion, CIPLA is one of the largest publicly traded companies.
CIPLA trades on the Indian stock exchanges (NSE/BSE) and is classified as a mega-cap-cap stock with a market capitalization of approximately $1.1 trillion. The company employs approximately 30,313 people worldwide.
Key Statistics
- Current Price
- ₹1,314.70
- Market Cap
- ₹1.06T
- 52-Week High
- ₹1,673.00
- 52-Week Low
- ₹1,281.70
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
CIPLA Investment Performance
CIPLA has declined 13.0% year-to-date in 2026. Over the past 5 years, a $1,000 investment in CIPLA would have grown to $1,622, representing a 62.1% total return. Since its IPO in 1996, a $1,000 investment would now be worth $181,882.
₹1,000 Invested in Cipla Limited (CIPLA)
How much would ₹1,000 invested in CIPLA be worth today?
What would ₹1,000 invested in CIPLA 1 year ago be worth today?
A ₹1,000 investment in Cipla Limited (CIPLA) in 2025 would be worth ₹911 as of May 2026, representing a -8.9% total return.
What would ₹1,000 invested in CIPLA 3 years ago be worth today?
A ₹1,000 investment in Cipla Limited (CIPLA) in 2023 would be worth ₹1,401 as of May 2026, representing a +40.1% total return.
What would ₹1,000 invested in CIPLA 5 years ago be worth today?
A ₹1,000 investment in Cipla Limited (CIPLA) in 2021 would be worth ₹1,622 as of May 2026, representing a +62.1% total return.
What would ₹1,000 invested in CIPLA 10 years ago be worth today?
A ₹1,000 investment in Cipla Limited (CIPLA) in 2016 would be worth ₹2,142 as of May 2026, representing a +114.2% total return.
What would ₹1,000 invested in CIPLA at IPO be worth today?
A ₹1,000 investment in Cipla Limited (CIPLA) at IPO would be worth ₹181,882 as of May 2026, representing a +18088.2% total return.
Monthly Returns Heatmap
Over the past 30+ years (362 months), Cipla Limited (CIPLA) has averaged a monthly return of +1.90% with a median return of +1.30%. The stock had 197 positive months (54%) and 165 negative months (46%). The best month in CIPLA's history was August 1999 with a +46.7% return, while the worst was October 2008 at -22.5%. Historically, August tends to be the strongest month (averaging +4.8%), and January the weakest (-1.5%).
CIPLA's longest winning streak was 10 consecutive months of gains, while its longest losing streak was 6 consecutive months of losses. The best full year was 1999 with a cumulative return of +185.0%, and the worst was 2002 at -21.4%.
Annual Returns
Over 30 years of trading history, Cipla Limited (CIPLA) has delivered an average annual return of +26.90% with a median return of +12.93%. The compound annual growth rate (CAGR) is +17.39%. The stock posted gains in 19 years (63%) and losses in 11 years (37%).
CIPLA's best year was 1999 with a +374.03% gain, while the worst was 2000 at -22.26%. The longest streak of consecutive positive years was 5, and the longest losing streak was 2 years. CIPLA achieved double-digit gains (10%+) in 16 years. It suffered double-digit losses in 8 years.
| Year | Return | Start | End |
|---|---|---|---|
| 2026 | -13.01% | ₹1,511.30 | ₹1,314.70 |
| 2025 | -0.10% | ₹1,512.84 | ₹1,511.30 |
| 2024 | +23.72% | ₹1,222.76 | ₹1,512.84 |
| 2023 | +16.77% | ₹1,047.13 | ₹1,222.76 |
| 2022 | +14.52% | ₹914.37 | ₹1,047.13 |
| 2021 | +15.78% | ₹789.78 | ₹914.37 |
| 2020 | +73.26% | ₹455.83 | ₹789.78 |
| 2019 | -7.42% | ₹492.34 | ₹455.83 |
| 2018 | -14.21% | ₹573.90 | ₹492.34 |
| 2017 | +7.36% | ₹534.56 | ₹573.90 |
| 2016 | -12.16% | ₹608.53 | ₹534.56 |
| 2015 | +4.02% | ₹585.02 | ₹608.53 |
| 2014 | +57.00% | ₹372.62 | ₹585.02 |
| 2013 | -2.76% | ₹383.18 | ₹372.62 |
| 2012 | +30.26% | ₹294.16 | ₹383.18 |
| 2011 | -12.92% | ₹337.81 | ₹294.16 |
| 2010 | +11.34% | ₹303.40 | ₹337.81 |
| 2009 | +80.88% | ₹167.74 | ₹303.40 |
| 2008 | -11.49% | ₹189.52 | ₹167.74 |
| 2007 | -14.48% | ₹221.62 | ₹189.52 |
| 2006 | +41.42% | ₹156.71 | ₹221.62 |
| 2005 | +42.39% | ₹110.05 | ₹156.71 |
| 2004 | +22.20% | ₹90.06 | ₹110.05 |
| 2003 | +48.31% | ₹60.73 | ₹90.06 |
| 2002 | -20.15% | ₹76.05 | ₹60.73 |
| 2001 | +9.05% | ₹69.74 | ₹76.05 |
| 2000 | -22.26% | ₹89.70 | ₹69.74 |
| 1999 | +374.03% | ₹18.92 | ₹89.70 |
| 1998 | +35.66% | ₹13.95 | ₹18.92 |
| 1997 | +30.09% | ₹10.72 | ₹13.95 |
CIPLA Investment Analysis: Valuation, Risk & Dividends
Key factors to consider when evaluating Cipla Limited as an investment
Valuation
CIPLA currently trades at a trailing P/E ratio of 23.4, which is considered moderate relative to the broader market. The forward P/E of 23.5 suggests analysts expect earnings to be higher in the coming year. The price-to-book ratio stands at 3.2. The price-to-sales ratio is 3.8.
Dividends
Cipla Limited pays a dividend to shareholders with a current yield of 0.99%. This translates to $13.00 per share annually. The payout ratio of 23% indicates sustainable dividend coverage.
Risk & Volatility
CIPLA has a beta of -0.04, indicating it is less volatile than the overall market. The stock's 52-week range is $1281.70 to $1673.00, and it currently trades near its 52-week low.
Analyst Ratings
Based on 36 analyst opinions, CIPLA has a consensus "none" rating. The average price target of $1446.31 suggests 10.0% upside from current levels.
Frequently Asked Questions: CIPLA
What sector is CIPLA in? ▼
CIPLA operates in the Healthcare sector, specifically in the Drug Manufacturers - Specialty & Generic industry. This sector includes pharmaceutical companies, biotechnology firms, medical device manufacturers, and healthcare providers.
How has CIPLA performed historically? ▼
Over 30 years of trading history, CIPLA has posted gains in 19 years (63% of the time). The best year was 1999 with a +374.0% return. Past performance does not guarantee future results.
How can I invest in CIPLA? ▼
You can invest in CIPLA through any brokerage account that offers access to Indian exchanges. Popular options include commission-free brokers like Fidelity, Charles Schwab, or Robinhood (US), or international brokers like Interactive Brokers. You can buy individual shares or invest through ETFs that hold CIPLA.
Does CIPLA pay dividends? ▼
Cipla Limited pays a dividend to shareholders with a current yield of 0.99%. This translates to $13.00 per share annually. The payout ratio of 23% indicates sustainable dividend coverage.
What does Cipla Limited do? ▼
Cipla Limited is a Drug Manufacturers - Specialty & Generic company operating in the Healthcare sector. The company is headquartered in Mumbai, India.
What sector is CIPLA in? ▼
CIPLA operates in the Healthcare sector, specifically in the Drug Manufacturers - Specialty & Generic industry.
When did CIPLA go public? ▼
Cipla Limited went public in 1996, making it a 30-year-old public company as of 2026.
How much would $1,000 invested in CIPLA 5 years ago be worth today? ▼
A $1,000 investment in CIPLA five years ago would be worth approximately $1,622 today, representing a 62.1% return.
Does CIPLA pay dividends? ▼
Yes, Cipla Limited pays a dividend with a current yield of 0.99%, which is $13.0 per share annually.
What is CIPLA's market cap? ▼
Cipla Limited has a market capitalization of $1.1 trillion, classifying it as a mega-cap company.
What is CIPLA's P/E ratio? ▼
CIPLA has a trailing P/E ratio of 23.4 and a forward P/E of 23.5, which measures how much investors are paying per dollar of earnings.
Is CIPLA a buy, hold, or sell? ▼
Based on 36 opinions, CIPLA has a consensus "none" rating. The average price target is $1446.31.
Last updated: 3/14/2026